The 12 closest competitors and alternatives to Kytopen Corp. among biotech, life sciences & techbio companies — ranked by similarity to what Kytopen Corp. actually does, not by market-cap band.
Subscribe to see Kytopen Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Kytopen Corp. is a biotech, life sciences & techbio company headquartered in United States. It has raised at least $57.1M across the 7 funding rounds on record, 6 of them with a disclosed amount. Its most recent funding round, Seed, closed in April 2026. Xcout tracks 18 named people at Kytopen Corp., including Michael Chiu (CEO, President and Treasurer).
12 more named people on record for Kytopen Corp., with roles, board committees and tenure — see the full roster →
At least $57.1M raised across the 7 rounds on record (6 with a disclosed amount). The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 3 named | |
| SEC Form D filing | $7.1M | — | |
| SEC Form D filing | $5.7M | — | |
| Seed | $32.5M | 3 named | |
| SEC Form D filing | $3.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Kytopen Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Biotechnology
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Biotech
Mytos, Inc. develops an automated cell manufacturing platform designed to scale cell-based therapies from clinical development to commercial production. Operating as an automated regenerative medicine CDMO, the company enables life sciences businesses to automate the production of stem cell-derived therapies.
Biotechnology
Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services for scientists, clinical researchers, and physicians to use in their basic research, translational research, and clinical applications. These services include techniques of sample preparation, cell separation, cell sorting, flow cytometry, spatial biology, cell culture, molecular analysis, clinical applications and small animal imaging. According to Miltenyi Biotec own internal sources, the company states that it has over 3,000 employees
Biotech
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
Biotechnology
CellBri is a cell therapy automation company that develops closed-system, cGMP-ready platforms for manufacturing CAR-T, NK, TCR-T, and stem cells without vendor lock-in.
Biotechnology
DeepCyte Inc. is an AI-powered biotechnology and toxicology platform headquartered in Wilmington, Delaware. Established in 2025, the company develops advanced computational tools for toxicity assessment and life sciences research.
Healthcare
Portal Biotechnologies, Inc. was founded in 2023 and is headquartered in Watertown, Massachusetts, focusing on advanced cell engineering techniques and drug discovery platforms.
Biotechnology
ThinkCyte is a biotechnology company founded in 2016 with offices in Tokyo, Japan and Redwood City, California. The company develops innovative technologies such as the VisionSort cell sorting system.
Biotech
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Biotech
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Biotech
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kytopen Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →